Merit Medical Systems (MMSI) Insider buying
5 open-market purchases of MMSI by Merit Medical Systems's executives and directors since May 2026, worth $573,294 in total, from SEC Form 4 filings.
Summary
The most recent: Christian Adam Smith, Chief Commercial Officer bought $99,186 on May 11, 2026.
The biggest buyer over the period is Michel J. Voigt (CHIEF HUMAN RESOURCES OFFICER): 1 purchase, $136,462.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 5 | $573,294 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Michel J. Voigt CHIEF HUMAN RESOURCES OFFICER | 1 | $136,462 |
| Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY | 1 | $125,250 |
| Martha Goldberg Aronson President and CEO | 1 | $120,880 |
| Christian Adam Smith Chief Commercial Officer | 1 | $99,186 |
| Raul Parra Jr. CFO AND TREASURER | 1 | $91,515 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| May 11, 2026 | Adam Smith Christian Chief Commercial Officer |
1,626 | $61.00 | $99,186 | Form 4 |
| May 7, 2026 | G. Lloyd Brian CHIEF LEGAL OFFICER, SECRETARY |
2,000 | $62.62 | $125,250 | Form 4 |
| May 6, 2026 | Goldberg Aronson Martha President and CEO |
2,000 | $60.44 | $120,880 | Form 4 |
| May 6, 2026 | Parra Raul Jr. CFO AND TREASURER |
1,500 | $61.01 | $91,515 | Form 4 |
| May 5, 2026 | J. Voigt Michel CHIEF HUMAN RESOURCES OFFICER |
2,250 | $60.65 | $136,462 | Form 4 |
Questions about Merit Medical Systems
Are Merit Medical Systems insiders buying the stock?
5 open-market purchases of MMSI by Merit Medical Systems's executives and directors since May 2026, worth $573,294 in total, from SEC Form 4 filings. The most recent: Christian Adam Smith, Chief Commercial Officer bought $99,186 on May 11, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Merit Medical Systems's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.